Results from Quipt Home Medical Corp (QIPT) show risk

While Quipt Home Medical Corp has underperformed by -2.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, QIPT fell by -44.79%, with highs and lows ranging from $4.07 to $1.35, whereas the simple moving average fell by -28.60% in the last 200 days.

On May 14, 2025, Canaccord Genuity Downgraded Quipt Home Medical Corp (NASDAQ: QIPT) to Hold. A report published by Raymond James on May 17, 2024, Downgraded its rating to ‘Underperform’ for QIPT. Canaccord Genuity Initiated an Buy rating on June 14, 2023, and assigned a price target of $11. The Benchmark Company initiated its ‘Buy’ rating for QIPT, as published in its report on October 20, 2021.

Analysis of Quipt Home Medical Corp (QIPT)

Further, the quarter-over-quarter decrease in sales is -6.32%, showing a negative trend in the upcoming months.

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Quipt Home Medical Corp’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -8.35% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.85, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

As an indicator of volatility for any stock, average volume can also be very valuable, and QIPT is recording an average volume of 906.32K. On a monthly basis, the volatility of the stock is set at 6.23%, whereas on a weekly basis, it is put at 2.87%, with a loss of -15.09% over the past seven days. Furthermore, long-term investors anticipate a median target price of $3.72, showing growth from the present price of $1.80, which can serve as yet another indication of whether QIPT is worth investing in or should be passed over.

How Do You Analyze Quipt Home Medical Corp Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 17.00%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 57.10% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

QIPT shares are owned by institutional investors to the tune of 57.10% at present.

Hot this week

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

Topics

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

A stock that deserves closer examination: Perpetua Resources Corp (PPTA)

While Perpetua Resources Corp has overperformed by 2.68%, investors...

Perspective Therapeutics Inc (CATX) deserves deeper analysis

While Perspective Therapeutics Inc has underperformed by -2.27%, investors...

Was Foremost Clean Energy Ltd (FMST)’s session last reading good?

While Foremost Clean Energy Ltd has overperformed by 2.80%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.